Aim. Dual Diagnosis issues are increasingly affecting Italian mental health services. Epidemiological surveys show high, though variable, comorbidity rates. It is paramount focussing main epidemiological, assessment and diagnostic features to set up adequate and effective services for Dual Diagnosis. Methods. A literature search was carried out using the Medline and PsychInfo databases (1970-July 2004). Results. Because of diagnostic issues screening and assessment questionnaires are recommended to detect populations at risk and evaluating psychosocial functioning. Both mental health and addiction services' clients should be targeted by such procedures. Personality disorders, mainly antisocial and borderline ones, are frequently diagnosed, as well as Mood Disorders with significant suicidal risk. Substance use comorbidity affects between 47% and 58% among psychotic patients. Conclusions. Treatment outcomes seem affected by: a) patient's motivation; b) team's optimum staffing and training, c) evidence based approach to program models and chosen therapeutic options.

Scioli, R., Restani, L., Clerici, M., Carra', G. (2006). Comorbidità psichiatrica nei disturbi da uso di sostanze. Epidemiologia, psicopatologia, screening ed assessment: una revisione narrativa. MINERVA PSICHIATRICA, 47(3), 231-242.

Comorbidità psichiatrica nei disturbi da uso di sostanze. Epidemiologia, psicopatologia, screening ed assessment: una revisione narrativa

CLERICI, MASSIMO;CARRA', GIUSEPPE
2006

Abstract

Aim. Dual Diagnosis issues are increasingly affecting Italian mental health services. Epidemiological surveys show high, though variable, comorbidity rates. It is paramount focussing main epidemiological, assessment and diagnostic features to set up adequate and effective services for Dual Diagnosis. Methods. A literature search was carried out using the Medline and PsychInfo databases (1970-July 2004). Results. Because of diagnostic issues screening and assessment questionnaires are recommended to detect populations at risk and evaluating psychosocial functioning. Both mental health and addiction services' clients should be targeted by such procedures. Personality disorders, mainly antisocial and borderline ones, are frequently diagnosed, as well as Mood Disorders with significant suicidal risk. Substance use comorbidity affects between 47% and 58% among psychotic patients. Conclusions. Treatment outcomes seem affected by: a) patient's motivation; b) team's optimum staffing and training, c) evidence based approach to program models and chosen therapeutic options.
Articolo in rivista - Articolo scientifico
Mental disorders, Substance abuse, Prevalence, Screening, Assessment
Italian
2006
47
3
231
242
none
Scioli, R., Restani, L., Clerici, M., Carra', G. (2006). Comorbidità psichiatrica nei disturbi da uso di sostanze. Epidemiologia, psicopatologia, screening ed assessment: una revisione narrativa. MINERVA PSICHIATRICA, 47(3), 231-242.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/14851
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
Social impact